Gabelli, Gamco cut stake in Greatbatch to 3.99%

By Jennifer Chiou

New York, Oct. 8 - Greatbatch, Inc. investors led by Gabelli Funds, LLC and Gamco Asset Management Inc. sold 266,000 shares of the company's stock.

The shares were sold between Aug. 15 and Oct. 7 at $22.7836 to $26.22 each, according to a schedule 13D/A filing with the Securities and Exchange Commission.

The investors beneficially own 911,950 shares, or 3.99%, of the Clarence, N.Y.-based company.

Greatbatch develops and manufactures critical components used in medical devices for the cardiac rhythm management, neurostimulation, vascular and interventional radiology markets.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.